 |
Ocugen up 18% in late-day tradingBrazil’s Health Ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the COVID-19 vaccine made by India’s Bharat Biotech. Ocugen recently finalized an agreement with Bharat to co-develop Bharat’s Covid-19 vaccine for the United States market. Research, News & Market Data on Ocugen |
 |
Xtant Medical Announces Closing of $20 million Private PlacementXtant Medical Holdings, Inc. announced the closing of its $20 million private placement to a single healthcare-focused institutional investor. The Company sold 8,888,890 common shares and warrants to purchase 6,666,668 common shares at a combined purchase price of $2.25 per share. |
 |
Lixte Biotechnology to Present Its Anti-Cancer Therapy Enhancer LB-100Lixte Biotechnology Holdings, Inc. announced it will present Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021. |
Stay up to date. Follow us:
 |
 |
 |
 |
 |
 |
Stay up to date. Follow us:
|
|
|
|
|
|